Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Caixin Futures Agricultural Market View: Palm Oil Leads the Gains, Meal Products and Corn Remain Strong

Caixin Futures Agricultural Market View: Palm Oil Leads the Gains, Meal Products and Corn Remain Strong

汇通财经汇通财经2026/03/16 12:56
Show original
⑴ Palm Oil: Fluctuating with a bullish tendency. Today, futures surpassed the 10,000 yuan mark. The Indonesian president instructed coal, crude palm oil, and derivative producers to prioritize domestic demand. The Coordinating Ministry for Economic Affairs stated that to mitigate the impact of oil prices, additional taxes may be imposed on commodities such as palm oil. The market expects Indonesia's export supply to tighten, which will support international prices. ⑵ Soybean Meal: Mainly buying on dips. The surge in crude oil has strengthened vegetable oils, thereby increasing the cost of imported soybeans, which is the main reason for the strength in soybean meal. Additionally, the demand for agricultural products as a hedge cannot be ignored. Recently, domestic soybean imports have declined significantly, and customs clearance delays have further tightened short-term supply, pushing meal prices higher. ⑶ Corn: Mainly buying on dips. The main reason for strong prices is that inventories at northern ports remain lower year-on-year, but downstream enterprise losses and warmer weather may limit further short-term gains. Prices are currently relatively high, so it is recommended to enter on dips after a pullback. ⑷ Live Hog: Mainly selling on rallies. Although the sow inventory has declined month-on-month, the absolute value is still higher than the normal holding level, and production performance remains excellent, so mid-term supply is still large. The second round of fattening before the New Year has not yet been fully digested, slaughter is gradually recovering, and post-holiday demand is weak, causing spot prices to continue to weaken. ⑸ Eggs: Mainly selling on rallies. After the holiday, sales and purchases are recovering slowly, logistics have not fully resumed, and currently, sales are mainly within production areas. From the perspective of supply and demand, supply in February and March remains large, and terminal demand is in the off-season.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ-Revolution Medicines stock drops due to concerns over pancreatic cancer drug data

On October 8, Revolution Medicines (RVMD.O) shares fell 8.1% in afternoon trading to $185.91. RBC Capital Markets stated that the share price decline appeared to be driven by the latest U.S. Food and Drug Administration (FDA) review documents regarding the company's pancreatic cancer drug Rasonque, particularly the disclosure of objective response rate data for specific RAS mutation subgroups. RBC pointed out that overall survival, rather than objective response rate, is a more meaningful indicator of efficacy, and that the sell-off overlooked Rasonque's broad activity across a variety of RAS mutation subgroups. RBC stated: "While we acknowledge that today's share price decline takes place against the backdrop of overall weakness in the biotech sector, we still believe that the market's reaction to the FDA review documents is an overreaction, given that the drug was approved on the basis of highly clinically meaningful efficacy and has received positive feedback from physicians." Including intraday fluctuations, the stock has more than doubled year-to-date. (Note: For the convenience of non-English speakers, Reuters has automatically translated its reports into several other languages. Automated translations may be inaccurate or lack necessary context; Reuters does not guarantee the accuracy of these automated translations and provides them only for reader convenience. Reuters does not accept liability for any damage or loss arising from the use of automated translation features.)

路透社•2026/10/08 18:26

BUZZ - Reports suggest Starbucks had discussed a deal, Chipotle shares rise

Latest Updates October 8 - Chipotle Mexican Grill shares (CMG.N) surged by as much as 8.55% to $33.40, while Starbucks (SBUX.O) shares once dropped 6.66% to $87.35. The Financial Times, citing insiders, reported that Starbucks (SBUX) had considered acquiring Chipotle (link). The coffee giant's stock has fallen to its lowest point since March. According to the report, the progress of the acquisition plan remains unclear; both Starbucks and Chipotle did not immediately respond to Reuters' requests for comment. If the deal goes through, CEO Brian Niccol would return to lead the Mexican grill chain he ran before joining the coffee giant two years ago. "For SBUX, we think investors would view this as a distraction for management's time and energy—after all, there is still much work to be done to revive the Starbucks brand, particularly concerning the fundamentals of same-store sales in North America, as the company gradually exhausts easily achievable growth points through 2027 and beyond," said RBC Capital Markets analyst Logan Reich. According to data from the London Stock Exchange Group (LSEG), CMG has a market capitalization of about $39 billions, while SBUX is valued at $107 billions. As of the close of the last trading day, SBUX has risen about 11% year-to-date, while CMG has fallen by 17%. (For the convenience of non-English speakers, Reuters has automated the translation of its reports into several other languages. As automated translations may be inaccurate or lack contextual nuances, Reuters does not guarantee the accuracy of translated texts, which are provided solely for reader convenience. Reuters accepts no liability for any loss or damage arising from the use of automated translations.)

路透社•2026/10/08 18:16

Market Chatter: Nvidia-Backed Firmus Grid Seen Delaying IPO

02:12 PM EDT, 10/08/2026 (MT Newswires) -- Nvidia-backed (NVDA) Firmus Grid is poised to delay its initial public offering amid slack investor demand, Bloomberg News reported Thursday, citing people familiar with the matter. The Australian data center company had been looking to raise as much as $5.5 billion including an overallotment option, indicating a $30.4 billion valuation, and may consider a private funding round instead, the report said. Firmus didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 230.30, Change: -7.17, Percent Change: -3.02

MT newswire•2026/10/08 18:12